Effect of Anordrin on serum levels of sex hormone binding globulin, caeruloplasmin and ovarian function.
Ten doses of 7.5 mg Anordrin were administered on alternate days from day 5 of the menstrual cycle to 20 women. Serum concentrations of both SHBG and CP were significantly increased after the fourth dose but the increases were minor compared to those produced by ethynyloestradiol. Two weeks after stopping Anordrin, serum concentrations of the proteins were still elevated in most women. Ovarian activity was studied in 8 women; serum oestradiol and progesterone concentrations indicated that ovulation occurred at the normal time in three women but was delayed for two weeks or more in the remaining five. The findings suggest that in humans, Anordrin acts as a weak oestrogen and may also have antioestrogenic activity.
Song
S
S
Shanghai Institute of Planned Parenthood Research, People's Republic of China.
Chen
J K
JK
He
M L
ML
Zuo
S H
SH
Fotherby
K
K
D000328:Adult; D002570:Ceruloplasmin / Q000097:blood*; D055598:Chemical Phenomena; D002621:Chemistry; D004997:Ethinyl Estradiol / Q000494:pharmacology; D005260:Female; D006801:Humans; D009635:Norandrostanes / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects*; D012738:Sex Hormone-Binding Globulin / Q000097:blood*; D013997:Time Factors
D009635:Norandrostanes; D012738:Sex Hormone-Binding Globulin; D004997:Ethinyl Estradiol; C010855:anordrin; D002570:Ceruloplasmin